Invesaro

Stocks ACIW Financial statements

Financial statements

ACI WORLDWIDE, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ACI WORLDWIDE, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,0061,0241,0101,2581,2941,3711,4221,4531,5941,760
Cost of revenue445452430617622639696719792898
Gross profit561572579641672732726733803862
Selling and marketing118108118124104127135133118125
General and administrative114153107135152124114117118143
Operating expenses785940884
Operating income22184.6126124145210204220308330
Interest expense40.23941.56456.645.153.278.572.557.8
Interest income0.530.5611.11211.611.512.514.215.914.9
Other non-operating income-35.5-41.1-34.1-51.5-46.1-34.82.8-72.8-57.7-23.2
Pre-tax income18643.691.872.298.6175207148250307
Income tax5638.422.95.152647.364.526.147.380
Net income1305.1468.967.172.7128142122203227
EBITDA325187223246285343331343419427
EPS, basic1.100.040.590.580.621.091.251.121.932.18
EPS, diluted1.090.040.590.570.621.081.241.121.912.16
Shares, basic (weighted)118118116116116117114108105104
Shares, diluted (weighted)119119118119118119114109106105
Dividend per share0.000.00

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents75.869.7149121165122125164216196
Receivables268263348151168320404452414446
Other current assets33.658.114.324.217.417.917.435.611.919.6
Total current assets4084225669201,1559371,1151,4079911,089
Property, plant and equipment7980.272.770.464.763.152.537.935.137.4
Lease right-of-use assets057.441.247.84034.328.928.7
Goodwill9109109101,2811,2801,2801,2261,2261,2261,231
Intangible assets204191168357322283229196165147
Other non-current assets39.136.552.172.754.162.567.263.353.529.1
Total assets1,9021,8622,1223,2583,3873,1593,2103,4453,0253,105
Accounts payable42.934.739.63741.241.3484645.464.9
Accrued liabilities47.848.938.129.348.651.445.353.955.656.1
Deferred revenue10510810565.895.884.458.359.675.473.6
Short-term debt90.317.820.834.134.345.965.574.434.940.9
Total current liabilities3763222976129067548591,037603706
Long-term debt6546686511,3391,1211,0201,024964890777
Lease liabilities046.84043.333.929.122.622.6
Other non-current liabilities41.238.443.644.639.934.5362526.928.8
Total liabilities1,1471,0971,0742,1282,1801,9142,0172,1201,6011,586
Total debt7446866721,3731,1551,0661,0901,038925818
Paid-in capital600610632668682688702713732762
Retained earnings5465518649311,0031,1311,2731,3951,5981,825
Treasury stock-298-320-356-378-388-476-666-675-785-965
Other comprehensive income-94.1-77.4-92.6-91.6-92.4-99.5-118-109-121-103
Shareholders' equity7557651,0481,1301,2071,2451,1931,3241,4241,519
Total equity7557651,0481,1301,2071,2451,1931,3241,4241,519
Total liabilities and equity1,9021,8622,1223,2583,3873,1593,2103,4453,0253,105
Shares outstanding117117116116117116108108105103

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income1305.1468.967.172.7128142122203227
Depreciation and amortization10310297.412314013312712211196.9
Stock-based compensation43.613.720.436.829.627.229.824.541.370.6
Deferred income tax17.721.7-5.73-22.13.353.731.6-4.09-13.10.94
Change in receivables-76.5-8.24-14.8-19.18.79-43.8-132-63-23.6-46.2
Change in payables-13.9-1.75.77-7.72.481.417.73-3.78-0.2711.3
Cash from operations99.8146184133315220143169359323
Capital expenditures-40.8-25.7-18.3-23.1-17.8-20.6-13.1-8.92-15.4-12.9
Acquisitions0.2300-75700
Cash from investing130-54.4-45.4-830-30.7-45.460.2-37.8-45.17.22
Debt issued040000
Debt repaid0-3000000-400
Stock issued2.992.963.13.593.763.443.582.822.923.42
Share buybacks-60.1-37.4-54.5-35.6-28.9-107-207-27.6-128-203
Cash from financing-251-98.1-57.7668-160-257-171-112-288-337
Exchange rate effect-4.870.32-2.08-1.5-0.060.53-2.044.960.70.57
Net change in cash-26.5-6.0478.8-31124-81.230.524.126.2-6.02
Free cash flow59120166110297200130160343310
Interest paid35.13535.3595240.148.573.570.264
Income taxes paid19.137.832.227.727.846.243.665.447.990

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $49.51 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin49.1%Gross profit / revenue.
Operating margin18.6%Operating income / revenue.
EBITDA margin24.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin16.8%Pre-tax income / revenue.
Net margin12.4%Net income / revenue.
FCF margin17.1%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin18.1%Cash from operations / revenue.
Effective tax rate26.4%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)15.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)7.3%Net income / average total assets.
Return on invested capital (ROIC)11.6%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue4.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.0%Capital expenditures / revenue.
D&A / revenue5.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y10.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y7.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y6.3%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y7.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y5.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y5.1%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y7.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y17.4%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y17.9%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y1.9%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y8.8%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y8.4%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y11.6%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y16.8%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y25.5%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y13.1%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y20.3%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y28.4%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-10.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y31.1%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y0.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-9.7%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y33.5%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y0.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y6.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y8.4%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y4.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y2.6%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-1.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-1.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-2.8%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-2.4%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.58xCurrent assets / current liabilities.
Quick ratio0.87x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.23x(Cash + short-term investments) / current liabilities.
Debt / equity0.55xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets26.6%Total debt / total assets.
Liabilities / assets51.6%Total liabilities / total assets.
Net debt$654.8MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA1.50xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage6.41xOperating income / interest expense.
Working capital$421.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets39.8%(Goodwill + intangible assets) / total assets.
Tangible book value$265.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.59xRevenue / average total assets.
Fixed asset turnover47.8xRevenue / average property, plant and equipment.
Receivables turnover3.96xRevenue / average receivables.
Days sales outstanding92 days365 x average receivables / revenue.
Days payables26 days365 x average accounts payable / cost of revenue.
FCF conversion138.0%Free cash flow / net income, when net income is positive.
Capex / operating cash flow5.6%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.22Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$17.90Revenue / diluted weighted shares.
FCF per share$3.06Free cash flow / diluted weighted shares.
Operating cash flow per share$3.24Cash from operations / diluted weighted shares.
Book value per share$14.79Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$2.63Tangible book value / shares outstanding.
Cash per share$1.65(Cash + short-term investments) / shares outstanding.
Buybacks / FCF56.4%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$5.00BShare price x shares outstanding.
Enterprise value$5.65BMarket cap + total debt - cash - short-term investments.
P/E22.1xMarket cap / net income. Only when net income is positive.
P/S2.75xMarket cap / revenue.
P/B3.34xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book18.8xMarket cap / tangible book value, when positive.
P/FCF16.1xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF15.2xMarket cap / cash from operations, when positive.
EV/Sales3.11xEnterprise value / revenue.
EV/EBIT16.7xEnterprise value / operating income, when both are positive.
EV/EBITDA12.9xEnterprise value / EBITDA, when both are positive.
EV/FCF18.2xEnterprise value / free cash flow, when both are positive.
FCF yield6.2%Free cash flow / market cap.
Earnings yield4.5%Net income / market cap (the inverse of P/E).
Shareholder yield3.5%(Dividends paid + share buybacks) / market cap.
PEG1.09xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was ACI WORLDWIDE, INC.'s revenue in fiscal 2025?

ACI WORLDWIDE, INC. reported revenue of $1.76B for fiscal 2025, 10.4% higher than the year before.

Was ACI WORLDWIDE, INC. profitable in fiscal 2025?

Yes. Net income was $226.7M, a net margin of 12.9%.

How much free cash flow did ACI WORLDWIDE, INC. generate in fiscal 2025?

Cash from operations of $322.8M minus capital expenditures of $12.9M left free cash flow of $309.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ACI WORLDWIDE, INC.